Bone tumors in Japan

Area of Science:

• Oncology
• Orthopedic Surgery
• Cancer Research

Background:

• The Japanese Registry of Bone Tumors collected data on 27,665 bone tumors between 1964 and 1980.
• Bone tumors represent a significant challenge in orthopedic oncology.

Purpose of the Study:

• To analyze treatment outcomes and survival rates for bone tumors in Japan.
• To evaluate the efficacy of adjuvant multidrug chemotherapy for osteosarcoma.
• To assess the prognosis of malignant fibrous histiocytoma.

Main Methods:

• Data compilation from the Japanese Registry of Bone Tumors (1964-1980).
• Retrospective analysis of treatment and survival data for osteosarcoma patients receiving adjuvant multidrug chemotherapy.
• Investigation of treatment and prognosis for 82 patients with malignant fibrous histiocytoma.

Main Results:

• The five-year cumulative survival rate for osteosarcoma treated with adjuvant multidrug chemotherapy was approximately 70%.
• The five-year cumulative survival rate for malignant fibrous histiocytoma was 50.3%.

Conclusions:

• Adjuvant multidrug chemotherapy demonstrates considerable efficacy in improving osteosarcoma survival rates.
• Malignant fibrous histiocytoma presents a poorer prognosis compared to osteosarcoma in this cohort.
• Long-term data from national registries are crucial for understanding bone tumor treatment outcomes.